The impact of reduced ovarian function after childhood cancer treatment

Anna Nyström

The impact of reduced ovarian function after childhood cancer treatment

Pediatrik, Lund

Forskningsoutput: Avhandling › Doktorsavhandling (sammanläggning)

74 Nedladdningar (Pure)

Originalspråk	engelska
Kvalifikation	Doktor
Tilldelande institution	Institutionen för kliniska vetenskaper, Lund
Handledare	Elfving, Maria, handledare Mörse, Helena, Biträdande handledare Øra, Ingrid, Biträdande handledare Henic, Emir, Biträdande handledare
Tilldelningsdatum	2025 mars 28
Utgivningsort	Lund
Förlag	Lund University, Faculty of Medicine
ISBN (tryckt)	978-91-8021-681-4
Status	Published - 2025

Bibliografisk information

Defence details
Date: 2025-03-28
Time: 10:00
Place: Belfragesalen, BMC D15, Klinikgatan 32 i Lund
External reviewer(s)
Name: Jahnukainen, Kirsi
Title: Professor
Affiliation: University of Helsinki, Helsinki, Finland

Ämnesklassifikation (UKÄ)

Pediatrik

FN:s Globala mål

Denna forskningsoutput relaterar till följande Globala mål

Tillgång till dokument

e-spik ex AnnaPublicerad version, 1,87 MB

3 Artikel i vetenskaplig tidskrift

Anti-Müllerian hormone and fertility in women after childhood cancer treatment: Association with current infertility risk classifications
Nyström, A., Mörse, H., Øra, I., Henic, E., Engellau, J., Wieslander, E., Tomaszewicz, A. & Elfving, M., 2024 aug., I: PLoS ONE. 19, 8, s. 1-18 e0308827.
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång
Quality of life among female childhood cancer survivors with and without premature ovarian insufficiency
Hjelmér, I., Gustafsson Kylberg, A., Fridenborg, A., Leijonhufvud, I., Nyström, A., Mörse, H., Elfving, M., Henic, E. & Hannah, N., 2023, I: Journal of Cancer Survivorship. 17, 1, s. 101-109
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång
Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment
Nyström, A., Mörse, H., Nordlöf, H., Wiebe, K., Artman, M., Øra, I., Giwercman, A., Henic, E. & Elfving, M., 2019, I: Acta Oncologica. 58, 2, s. 218-224
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång

Citera det här

@phdthesis{af61b41dc6524d1695e3596b03446f87,

title = "The impact of reduced ovarian function after childhood cancer treatment",

keywords = "childhood cancer survivors, anti-M{\"u}llerian hormone, Premature ovarian insufficiency, quality of life, fertility, age at diagnosis",

author = "Anna Nystr{\"o}m",

note = "Defence details Date: 2025-03-28 Time: 10:00 Place: Belfragesalen, BMC D15, Klinikgatan 32 i Lund External reviewer(s) Name: Jahnukainen, Kirsi Title: Professor Affiliation: University of Helsinki, Helsinki, Finland",

year = "2025",

language = "English",

isbn = "978-91-8021-681-4",

series = "Lund University, Faculty of Medicine Doctoral Dissertation Series",

publisher = "Lund University, Faculty of Medicine",

number = "2025:28",

type = "Doctoral Thesis (compilation)",

school = "Department of Clinical Sciences, Lund",

}

TY - THES

T1 - The impact of reduced ovarian function after childhood cancer treatment

AU - Nyström, Anna

N1 - Defence details Date: 2025-03-28 Time: 10:00 Place: Belfragesalen, BMC D15, Klinikgatan 32 i Lund External reviewer(s) Name: Jahnukainen, Kirsi Title: Professor Affiliation: University of Helsinki, Helsinki, Finland

PY - 2025

Y1 - 2025

KW - childhood cancer survivors

KW - anti-Müllerian hormone

KW - Premature ovarian insufficiency

KW - quality of life

KW - fertility

KW - age at diagnosis

M3 - Doctoral Thesis (compilation)

SN - 978-91-8021-681-4

T3 - Lund University, Faculty of Medicine Doctoral Dissertation Series

PB - Lund University, Faculty of Medicine

CY - Lund

ER -

The impact of reduced ovarian function after childhood cancer treatment

Bibliografisk information

Ämnesklassifikation (UKÄ)

FN:s Globala mål

Tillgång till dokument

Forskningsoutput

Anti-Müllerian hormone and fertility in women after childhood cancer treatment: Association with current infertility risk classifications

Quality of life among female childhood cancer survivors with and without premature ovarian insufficiency

Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment

Citera det här